Katie Brookes
YOU?
Author Swipe
View article: Targeting Src tyrosine kinase to enhance radioiodide uptake in breast cancer
Targeting Src tyrosine kinase to enhance radioiodide uptake in breast cancer Open
Sodium iodide symporter (NIS) expression in breast cancer renders radioiodide (RAI) a promising treatment modality. However, insufficient functional NIS within the plasma membrane limits RAI uptake (RAIU). We aimed to elucidate NIS regulat…
View article: Abstracts from the 72nd Annual Meeting of the British Thyroid Association
Abstracts from the 72nd Annual Meeting of the British Thyroid Association Open
Background: Multiple endocrine neoplasia type 2 (MEN2) is an inherited condition caused by RET proto-oncogene mutations and is responsible for approximately 20% of medullary thyroid cancer (MTC) cases. Predicting the onset of MTC in MEN2 p…
View article: Supplementary Figure S7 from Combined Vorinostat and Chloroquine Inhibit Sodium–Iodide Symporter Endocytosis and Enhance Radionuclide Uptake <i>In Vivo</i>
Supplementary Figure S7 from Combined Vorinostat and Chloroquine Inhibit Sodium–Iodide Symporter Endocytosis and Enhance Radionuclide Uptake <i>In Vivo</i> Open
Supplementary Figure S7
View article: Supplementary Table S2 from Combined Vorinostat and Chloroquine Inhibit Sodium–Iodide Symporter Endocytosis and Enhance Radionuclide Uptake <i>In Vivo</i>
Supplementary Table S2 from Combined Vorinostat and Chloroquine Inhibit Sodium–Iodide Symporter Endocytosis and Enhance Radionuclide Uptake <i>In Vivo</i> Open
Supplementary Table S2
View article: Supplementary Figure S11 from Combined Vorinostat and Chloroquine Inhibit Sodium–Iodide Symporter Endocytosis and Enhance Radionuclide Uptake <i>In Vivo</i>
Supplementary Figure S11 from Combined Vorinostat and Chloroquine Inhibit Sodium–Iodide Symporter Endocytosis and Enhance Radionuclide Uptake <i>In Vivo</i> Open
Supplementary Figure S11
View article: Supplementary Figure S3 from Combined Vorinostat and Chloroquine Inhibit Sodium–Iodide Symporter Endocytosis and Enhance Radionuclide Uptake <i>In Vivo</i>
Supplementary Figure S3 from Combined Vorinostat and Chloroquine Inhibit Sodium–Iodide Symporter Endocytosis and Enhance Radionuclide Uptake <i>In Vivo</i> Open
Supplementary Figure S3
View article: Supplementary Figure S2 from Combined Vorinostat and Chloroquine Inhibit Sodium–Iodide Symporter Endocytosis and Enhance Radionuclide Uptake <i>In Vivo</i>
Supplementary Figure S2 from Combined Vorinostat and Chloroquine Inhibit Sodium–Iodide Symporter Endocytosis and Enhance Radionuclide Uptake <i>In Vivo</i> Open
Supplementary Figure S2
View article: Supplementary Figure S2 from Combined Vorinostat and Chloroquine Inhibit Sodium–Iodide Symporter Endocytosis and Enhance Radionuclide Uptake <i>In Vivo</i>
Supplementary Figure S2 from Combined Vorinostat and Chloroquine Inhibit Sodium–Iodide Symporter Endocytosis and Enhance Radionuclide Uptake <i>In Vivo</i> Open
Supplementary Figure S2
View article: Supplementary Figure S8 from Combined Vorinostat and Chloroquine Inhibit Sodium–Iodide Symporter Endocytosis and Enhance Radionuclide Uptake <i>In Vivo</i>
Supplementary Figure S8 from Combined Vorinostat and Chloroquine Inhibit Sodium–Iodide Symporter Endocytosis and Enhance Radionuclide Uptake <i>In Vivo</i> Open
Supplementary Figure S8
View article: Supplementary Figure S6 from Combined Vorinostat and Chloroquine Inhibit Sodium–Iodide Symporter Endocytosis and Enhance Radionuclide Uptake <i>In Vivo</i>
Supplementary Figure S6 from Combined Vorinostat and Chloroquine Inhibit Sodium–Iodide Symporter Endocytosis and Enhance Radionuclide Uptake <i>In Vivo</i> Open
Supplementary Figure S6
View article: Supplementary Figure S4 from Combined Vorinostat and Chloroquine Inhibit Sodium–Iodide Symporter Endocytosis and Enhance Radionuclide Uptake <i>In Vivo</i>
Supplementary Figure S4 from Combined Vorinostat and Chloroquine Inhibit Sodium–Iodide Symporter Endocytosis and Enhance Radionuclide Uptake <i>In Vivo</i> Open
Supplementary Figure S4
View article: Supplementary Figure S5 from Combined Vorinostat and Chloroquine Inhibit Sodium–Iodide Symporter Endocytosis and Enhance Radionuclide Uptake <i>In Vivo</i>
Supplementary Figure S5 from Combined Vorinostat and Chloroquine Inhibit Sodium–Iodide Symporter Endocytosis and Enhance Radionuclide Uptake <i>In Vivo</i> Open
Supplementary Figure S5
View article: Supplementary Figure S6 from Combined Vorinostat and Chloroquine Inhibit Sodium–Iodide Symporter Endocytosis and Enhance Radionuclide Uptake <i>In Vivo</i>
Supplementary Figure S6 from Combined Vorinostat and Chloroquine Inhibit Sodium–Iodide Symporter Endocytosis and Enhance Radionuclide Uptake <i>In Vivo</i> Open
Supplementary Figure S6
View article: Supplementary Figure S1 from Combined Vorinostat and Chloroquine Inhibit Sodium–Iodide Symporter Endocytosis and Enhance Radionuclide Uptake <i>In Vivo</i>
Supplementary Figure S1 from Combined Vorinostat and Chloroquine Inhibit Sodium–Iodide Symporter Endocytosis and Enhance Radionuclide Uptake <i>In Vivo</i> Open
Supplementary Figure S1
View article: Supplementary Table S2 from Combined Vorinostat and Chloroquine Inhibit Sodium–Iodide Symporter Endocytosis and Enhance Radionuclide Uptake <i>In Vivo</i>
Supplementary Table S2 from Combined Vorinostat and Chloroquine Inhibit Sodium–Iodide Symporter Endocytosis and Enhance Radionuclide Uptake <i>In Vivo</i> Open
Supplementary Table S2
View article: Supplementary Figure S8 from Combined Vorinostat and Chloroquine Inhibit Sodium–Iodide Symporter Endocytosis and Enhance Radionuclide Uptake <i>In Vivo</i>
Supplementary Figure S8 from Combined Vorinostat and Chloroquine Inhibit Sodium–Iodide Symporter Endocytosis and Enhance Radionuclide Uptake <i>In Vivo</i> Open
Supplementary Figure S8
View article: Supplementary Table S3 from Combined Vorinostat and Chloroquine Inhibit Sodium–Iodide Symporter Endocytosis and Enhance Radionuclide Uptake <i>In Vivo</i>
Supplementary Table S3 from Combined Vorinostat and Chloroquine Inhibit Sodium–Iodide Symporter Endocytosis and Enhance Radionuclide Uptake <i>In Vivo</i> Open
Supplementary Table S3
View article: Supplementary Figure S9 from Combined Vorinostat and Chloroquine Inhibit Sodium–Iodide Symporter Endocytosis and Enhance Radionuclide Uptake <i>In Vivo</i>
Supplementary Figure S9 from Combined Vorinostat and Chloroquine Inhibit Sodium–Iodide Symporter Endocytosis and Enhance Radionuclide Uptake <i>In Vivo</i> Open
Supplementary Figure S9
View article: Supplementary Table S1 from Combined Vorinostat and Chloroquine Inhibit Sodium–Iodide Symporter Endocytosis and Enhance Radionuclide Uptake <i>In Vivo</i>
Supplementary Table S1 from Combined Vorinostat and Chloroquine Inhibit Sodium–Iodide Symporter Endocytosis and Enhance Radionuclide Uptake <i>In Vivo</i> Open
Supplementary Table S1
View article: Supplementary Table S3 from Combined Vorinostat and Chloroquine Inhibit Sodium–Iodide Symporter Endocytosis and Enhance Radionuclide Uptake <i>In Vivo</i>
Supplementary Table S3 from Combined Vorinostat and Chloroquine Inhibit Sodium–Iodide Symporter Endocytosis and Enhance Radionuclide Uptake <i>In Vivo</i> Open
Supplementary Table S3
View article: Supplementary Figure S7 from Combined Vorinostat and Chloroquine Inhibit Sodium–Iodide Symporter Endocytosis and Enhance Radionuclide Uptake <i>In Vivo</i>
Supplementary Figure S7 from Combined Vorinostat and Chloroquine Inhibit Sodium–Iodide Symporter Endocytosis and Enhance Radionuclide Uptake <i>In Vivo</i> Open
Supplementary Figure S7
View article: Supplementary Figure S10 from Combined Vorinostat and Chloroquine Inhibit Sodium–Iodide Symporter Endocytosis and Enhance Radionuclide Uptake <i>In Vivo</i>
Supplementary Figure S10 from Combined Vorinostat and Chloroquine Inhibit Sodium–Iodide Symporter Endocytosis and Enhance Radionuclide Uptake <i>In Vivo</i> Open
Supplementary Figure S10
View article: Supplementary Figure S10 from Combined Vorinostat and Chloroquine Inhibit Sodium–Iodide Symporter Endocytosis and Enhance Radionuclide Uptake <i>In Vivo</i>
Supplementary Figure S10 from Combined Vorinostat and Chloroquine Inhibit Sodium–Iodide Symporter Endocytosis and Enhance Radionuclide Uptake <i>In Vivo</i> Open
Supplementary Figure S10
View article: Supplementary Figure S1 from Combined Vorinostat and Chloroquine Inhibit Sodium–Iodide Symporter Endocytosis and Enhance Radionuclide Uptake <i>In Vivo</i>
Supplementary Figure S1 from Combined Vorinostat and Chloroquine Inhibit Sodium–Iodide Symporter Endocytosis and Enhance Radionuclide Uptake <i>In Vivo</i> Open
Supplementary Figure S1
View article: Data from Combined Vorinostat and Chloroquine Inhibit Sodium–Iodide Symporter Endocytosis and Enhance Radionuclide Uptake <i>In Vivo</i>
Data from Combined Vorinostat and Chloroquine Inhibit Sodium–Iodide Symporter Endocytosis and Enhance Radionuclide Uptake <i>In Vivo</i> Open
Purpose:Patients with aggressive thyroid cancer are frequently failed by the central therapy of ablative radioiodide (RAI) uptake, due to reduced plasma membrane (PM) localization of the sodium/iodide symporter (NIS). We aimed to understan…
View article: Supplementary Figure S11 from Combined Vorinostat and Chloroquine Inhibit Sodium–Iodide Symporter Endocytosis and Enhance Radionuclide Uptake <i>In Vivo</i>
Supplementary Figure S11 from Combined Vorinostat and Chloroquine Inhibit Sodium–Iodide Symporter Endocytosis and Enhance Radionuclide Uptake <i>In Vivo</i> Open
Supplementary Figure S11
View article: Supplementary Figure S9 from Combined Vorinostat and Chloroquine Inhibit Sodium–Iodide Symporter Endocytosis and Enhance Radionuclide Uptake <i>In Vivo</i>
Supplementary Figure S9 from Combined Vorinostat and Chloroquine Inhibit Sodium–Iodide Symporter Endocytosis and Enhance Radionuclide Uptake <i>In Vivo</i> Open
Supplementary Figure S9
View article: Supplementary Figure S4 from Combined Vorinostat and Chloroquine Inhibit Sodium–Iodide Symporter Endocytosis and Enhance Radionuclide Uptake <i>In Vivo</i>
Supplementary Figure S4 from Combined Vorinostat and Chloroquine Inhibit Sodium–Iodide Symporter Endocytosis and Enhance Radionuclide Uptake <i>In Vivo</i> Open
Supplementary Figure S4
View article: Supplementary Table S1 from Combined Vorinostat and Chloroquine Inhibit Sodium–Iodide Symporter Endocytosis and Enhance Radionuclide Uptake <i>In Vivo</i>
Supplementary Table S1 from Combined Vorinostat and Chloroquine Inhibit Sodium–Iodide Symporter Endocytosis and Enhance Radionuclide Uptake <i>In Vivo</i> Open
Supplementary Table S1
View article: Supplementary Information 1 from Combined Vorinostat and Chloroquine Inhibit Sodium–Iodide Symporter Endocytosis and Enhance Radionuclide Uptake <i>In Vivo</i>
Supplementary Information 1 from Combined Vorinostat and Chloroquine Inhibit Sodium–Iodide Symporter Endocytosis and Enhance Radionuclide Uptake <i>In Vivo</i> Open
This file contains Supplementary Materials and Methods, as well as Supplementary References.